These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2464275)

  • 21. Effects of chronic treatment with oestrogen, an oestrogen antagonist and a potent luteinizing hormone releasing hormone agonist analogue on pituitary responsiveness to luteinizing hormone releasing hormone in the rat.
    Hall JM; Whitehead SA
    J Endocrinol; 1983 Sep; 98(3):313-21. PubMed ID: 6413634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rapid effects of luteinizing hormone releasing hormone agonists and antagonists on the mouse pituitary in vitro.
    Kato K; Sairam MR
    Life Sci; 1983 Jan; 32(3):263-70. PubMed ID: 6401836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New, highly active antagonists of LHRH with acylated lysine and p-aminophenylalanine in positions 5 and 6.
    Janecka A; Janecki T; Bowers CY; Folkers K
    Int J Pept Protein Res; 1994 Jul; 44(1):19-23. PubMed ID: 7960400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6.
    Folkers K; Bowers C; Xiao SB; Tang PF; Kubota M
    Biochem Biophys Res Commun; 1986 Jun; 137(2):709-15. PubMed ID: 2425802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteinizing hormone releasing hormone mediates naloxone's effects on serum luteinizing hormone levels in normal and morphine-sensitized male rats.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT
    Life Sci; 1985 Aug; 37(5):467-74. PubMed ID: 3894852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding kinetics of the long-acting gonadotropin-releasing hormone (GnRH) antagonist antide to rat pituitary GnRH receptors.
    Li SL; Vuagnat B; Gruaz NM; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1994 Jul; 135(1):45-52. PubMed ID: 8013383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LHRH-pituitary plasma membrane binding: the presence of specific binding sites in other tissues.
    Marshall JC; Shakespear RA; Odell WD
    Clin Endocrinol (Oxf); 1976 Nov; 5(6):671-7. PubMed ID: 188571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormone.
    Folkers K; Bowers CY; Tang PF; Kubota M
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1070-4. PubMed ID: 3081889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of luteinizing hormone-releasing hormone antagonistic activity in vitro.
    Csernus VJ; Schally AV
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5759-63. PubMed ID: 1631057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteinizing hormone-releasing hormone inactivation by purified pituitary plasma membranes: effects of receptor-binding studies.
    Clayton RN; Shakespear RA; Duncan JA; Marshall JC
    Endocrinology; 1979 May; 104(5):1484-94. PubMed ID: 220037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin inhibits luteinizing hormone releasing hormone (LHRH) induction of LH release from fetal rat pituitary cells.
    Hattori A; Herbert DC; Vaughan MK; Yaga K; Reiter RJ
    Neurosci Lett; 1995 Jan; 184(2):109-12. PubMed ID: 7724042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties.
    Theobald P; Porter J; Rivier C; Corrigan A; Hook W; Siraganian R; Perrin M; Vale W; Rivier J
    J Med Chem; 1991 Aug; 34(8):2395-402. PubMed ID: 1714956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo.
    Molineaux CJ; Lasdun A; Michaud C; Orlowski M
    J Neurochem; 1988 Aug; 51(2):624-33. PubMed ID: 3292705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prolonged action of the LHRH agonist buserelin (HOE 766) may be due to prolonged binding to the LHRH receptor.
    Koiter TR; Denef C; Andries M; Moes H; Schuiling GA
    Life Sci; 1986 Aug; 39(5):443-52. PubMed ID: 3016440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific binding of a potent LHRH agonist in rat testis.
    Lefebvre FA; Reeves JJ; Séguin C; Massicotte J; Labrie F
    Mol Cell Endocrinol; 1980 Nov; 20(2):127-34. PubMed ID: 6777213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some characteristics of GnRH receptors in rat-pituitary membranes: differences between an agonist and and antagonist.
    Hazum E
    Mol Cell Endocrinol; 1981 Sep; 23(3):275-81. PubMed ID: 6269924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
    Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs.
    Moradi SV; Varamini P; Toth I
    AAPS J; 2015 Sep; 17(5):1135-43. PubMed ID: 25956382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteinizing hormone secretion from the quail pituitary in vitro.
    Connolly PB; Callard IP
    Biol Reprod; 1987 Jun; 36(5):1238-46. PubMed ID: 3304437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, luteinizing hormone-releasing activity, and receptor binding of chicken hypothalamic luteinizing hormone-releasing hormone.
    Millar RP; King JA
    Endocrinology; 1983 Oct; 113(4):1364-9. PubMed ID: 6311518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.